Treatments for Epilepsy

Below is a listing of treatments and therapies for epilepsy. Click on one to read more information or connect with others currently using it.

View:

Aptiom (Eslicarbazepine)

Aptiom is a prescription medication approved by the Food and Drug Administration (FDA) in 2013 for the treatment of partial seizures in adults. Aptiom may be added to a person’s existing medications when t... read more

Banzel (Rufinamide)

Overview
Banzel is a prescription drug approved by the Food and Drug Administration (FDA) to treat seizures associated with Lennox-Gastaut Syndrome in people one year and older. Banzel is indicated as an adjun... read more

Briviact (Brivaracetam)

Overview
Briviact is approved by the Food and Drug Administration (FDA) to treat partial-onset seizures in people 16 years and older who have epilepsy. Briviact is used as an adjunctive therapy along with anot... read more

Carbamazepine

Overview
Carbamazepine is a prescription medication approved by the Food and Drug Administration (FDA) in 1968 for the treatment of seizures. In people with epilepsy, Carbamazepine is used to prevent most type... read more

Carbatrol (Carbamazepine)

Overview
Carbatrol is a prescription medication approved by the Food and Drug Administration (FDA) in 1968 for the treatment of seizures. In people with epilepsy, Carbatrol is used to prevent most types of sei... read more

Carnexiv (Carbamazepine)

Overview
Carnexiv is a prescription drug approved by the Food and Drug Administration (FDA) to temporarily replace oral Carbamazepine therapy in adults with generalized tonic-clonic seizures and some types of ... read more

Clonazepam

Overview
According to the Australian Medicines Handbook (AMH), Clonazepam is prescribed in conjunction with antiepileptic drugs (AEDs) if the AEDs alone are not adequately effective. As an adjunct to AEDs, Clo... read more

Complementary and alternative therapies

Overview

Studies show that as many as 44 percent of people with epilepsy in the U.S. try incorporating non-traditional therapies into their treatment plan. These treatments may be in addition to (complementa... read more

Corpus callosotomy

Overview

Approximately 20 percent of people with epilepsy cannot adequately control their seizures with anti-epileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their q... read more

Depacon (Valproate sodium)

Overview
Depacon is approved by the Food and Drug Administration (FDA) to treat several types of seizures. In some situations, Depacon is used as a monotherapy, but in some cases Depacon is used as an adjuncti... read more

Depakene (Valproic acid)

Overview
Depakene is a prescription drug that was approved by the Food and Drug Administration (FDA) in 1978 to treat epilepsy. Depakene is also referred to by its drug name, Valproate or Valproic acid. Anothe... read more

Depakote (Divalproex sodium)

Depakote is a prescription drug that was approved by the Food and Drug Administration (FDA) in 1983 to treat epilepsy. Depakote is also referred to by its drug name, Divalproex sodium. Within the body, Dep... read more

Diamox (Acetazolamide)

Overview
Diamox is one brand name for Acetazolamide. According to the Australian Medicines Handbook (AMH), Acetazolamide is indicated for the treatment of epilepsy. Acetazolamide may be prescribed for absence ... read more

Dilantin (Phenytoin)

Overview
Dilantin is a prescription medication approved by the Food and Drug Administration (FDA) more than 50 years ago for the treatment of seizures. In people with epilepsy, Dilantin is most effective for p... read more

Epidiolex (Cannabidiol)

Overview
Epidiolex is a prescription drug approved by the Food and Drug Administration (FDA) to treat seizures associated with Dravet syndrome or Lennox-Gastaut syndrome in people age 2 and older. Epidiolex is... read more

Epilim (Valproate)

Overview
Epilim is one brand name for Valproate. According to the Australian Medicines Handbook (AMH), Valproate is indicated for primary generalised epilepsy and simple and complex focal (partial) seizures.
... read more

Epiramax (Topiramate)

Overview
Epiramax is one brand name for Topiramate. According to the Australian Medicines Handbook (AMH), Topiramate is indicated for focal (partial) seizures, generalised tonic-clonic seizures, and drop attac... read more

Extratemporal cortical resection

Overview

Approximately 20 percent of people with epilepsy cannot adequately control their seizures with anti-epileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their q... read more

Felbatol (Felbamate)

Felbatol is a prescription medication approved by the Food and Drug Administration (FDA) in 1993. It is approved for the treatment of severe epilepsy when other drugs cannot effectively control seizures. S... read more

Frisium (Clobazam)

Overview
Frisium is a brand name for Clobazam. According to the Australian Medicines Handbook (AMH), Clobazam may be prescribed for acute treatment of seizures or in conjunction with antiepileptic drugs (AEDs)... read more

Frontal lobectomy

Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their qual... read more

Functional hemispherectomy

Overview

Approximately 20 percent of people with epilepsy cannot adequately control their seizures with anti-epileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their q... read more

Fycompa (Perampanel)

Fycompa is a prescription medication approved by the Food and Drug Administration (FDA) in 2012 for the treatment of partial seizures in people with epilepsy who are 12 years and older. Fycompa is also kno... read more

Gabapentin

Overview
According to the Australian Medicines Handbook (AMH), Gabapentin is indicated to treat focal (partial) seizures not controlled adequately by other antiepileptic drugs.

Gabapentin is an antiepilept... read more

Gabaran (Gabapentin)

Overview
Gabaran is a brand name for Gabapentin. According to the Australian Medicines Handbook (AMH), Gabapentin is indicated to treat focal (partial) seizures not controlled adequately by other antiepileptic... read more

Gabitril (Tiagabine)

Gabitril is a prescription medication approved by the Food and Drug Administration (FDA) in 1997 for the treatment of partial seizures in people with epilepsy who are 12 years and older. Gabitril is usuall... read more

Gantin (Gabapentin)

Overview
Gantin is a brand name for Gabapentin. According to the Australian Medicines Handbook (AMH), Gabapentin is indicated to treat focal (partial) seizures not controlled adequately by other antiepileptic ... read more

Keppra (Levetiracetam)

Overview
Keppra is a prescription medication approved by the Food and Drug Administration (FDA) in 1999. Keppra is prescribed for the treatment of partial onset seizures in people with epilepsy ages one month ... read more

Kerron (Levetiracetam)

Overview
Kerron is one brand name for Levetiracetam. According to the Australian Medicines Handbook (AMH), Levetiracetam is indicated for focal (partial) seizures, for primary generalised tonic-clonic seizures... read more

Ketogenic diet

Overview
The ketogenic diet is high in fat and low in carbohydrates. Doctors may recommend the ketogenic diet for children whose epilepsy does not respond to AEDs.

What does it involve?
The ketogen... read more

Klonopin (Clonazepam)

Klonopin is a prescription medication approved by the Food and Drug Administration (FDA) in 1975. In cases of epilepsy, Klonopin may be prescribed in addition to the medications you are already taking if t... read more

Lamictal (Lamotrigine)

Lamictal is a prescription medication approved by the Food and Drug Administration (FDA) in 1994 for the treatment of many different types of seizures. Lamictal is usually prescribed as an adjunctive medic... read more

Lamidus (Lamotrigine)

Overview
Lamidus is one brand name for Lamotrigine. According to the Australian Medicines Handbook (AMH), Lamotrigine is indicated for focal (partial) and generalised seizures.

Lamidus is an antiepileptic, ... read more

Lamotrigine

Overview
According to the Australian Medicines Handbook (AMH), Lamotrigine is indicated for focal (partial) and generalised seizures.

Lamotrigine is an antiepileptic, or drug that prevents seizures. It is b... read more

Lamotrust (Lamotrigine)

Overview
Lamotrust is one brand name for Lamotrigine. According to the Australian Medicines Handbook (AMH), Lamotrigine is indicated for focal (partial) and generalised seizures.

Lamotrust is an antiepilept... read more

Lesionectomy

Overview

Approximately 20 percent of people with epilepsy cannot adequately control their seizures with anti-epileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their q... read more

Levactam (Levetiracetam)

Overview
Levactam is one brand name for Levetiracetam. According to the Australian Medicines Handbook (AMH), Levetiracetam is indicated for focal (partial) seizures, for primary generalised tonic-clonic seizur... read more

Levetiracetam

Overview
According to the Australian Medicines Handbook (AMH), Levetiracetam is indicated for focal (partial) seizures, for primary generalised tonic-clonic seizures associated with idiopathic generalised epil... read more

Levi (Levetiracetam)

Overview
Levi is one brand name for Levetiracetam. According to the Australian Medicines Handbook (AMH), Levetiracetam is indicated for focal (partial) seizures, for primary generalised tonic-clonic seizures a... read more

Levitaccord (Levetiracetam)

Overview
Levitaccord is one brand name for Levetiracetam. According to the Australian Medicines Handbook (AMH), Levetiracetam is indicated for focal (partial) seizures, for primary generalised tonic-clonic sei... read more

Logem (Lamotrigine)

Overview
Logem is one brand name for Lamotrigine. According to the Australian Medicines Handbook (AMH), Lamotrigine is indicated for focal (partial) and generalised seizures.

Logem is an antiepileptic, or d... read more

Lyrica (Pregabalin)

Lyrica is a prescription medication approved by the Food and Drug Administration (FDA) in 2005 as an adjunctive medication for the treatment of partial seizures in adults with epilepsy. Lyrica is usually p... read more

Melatonin

Overview

Melatonin is a hormone that promotes sleep. Melatonin is produced naturally by the body. Studies have shown that people with epilepsy have lower-than-normal levels of melatonin. It is unknown whethe... read more

Multiple subpial transection (MST)

Overview

Approximately 20 percent of people with epilepsy cannot adequately control their seizures with anti-epileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their q... read more

Mysoline (Primidone)

Mysoline is a prescription medication approved by the Federal Drug Administration (FDA) in 1954 to control seizure types including psychomotor, grand mal, and focal epileptic seizures. Mysoline is also kno... read more

Nayzilam (Midazolam)

Overview
Nayzilam is a prescription drug approved by the Food and Drug Administration (FDA) as a short-term treatment for seizure clusters in people 12 years of age and older. Nayzilam is also known by its dr... read more

Neurontin (Gabapentin)

Neurontin is a prescription medication approved by the Food and Drug Administration (FDA) in 1993 as an adjunctive medication for the treatment of partial seizures in people with epilepsy who are three yea... read more

Nupentin (Gabapentin)

Overview
Nupentin is a brand name for Gabapentin. According to the Australian Medicines Handbook (AMH), Gabapentin is indicated to treat focal (partial) seizures not controlled adequately by other antiepilepti... read more

Occipital lobectomy

Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their qual... read more

Ospolot (Sulthiame)

Overview
Ospolot is a brand name for Sulthiame. According to the Australian Medicines Handbook (AMH), Sulthiame is indicated for epilepsy, especially temporal lobe and myoclonic seizures. Sulthiame may also be... read more

Oxtellar XR (Oxcarbazepine)

Oxtellar XR is a prescription medication approved by the Food and Drug Administration (FDA) in 2000 for the treatment of partial seizures in people age two years and old. Oxtellar XR may be prescribed as a... read more

Parietal lobectomy

Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their qual... read more

Paxam (Clonazepam)

Overview
Paxam is one brand name for Clonazepam. According to the Australian Medicines Handbook (AMH), Clonazepam is prescribed in conjunction with antiepileptic drugs (AEDs) if the AEDs alone are not adequate... read more

Phenobarbital

Phenobarbital is a prescription medication that has been sold since 1912 for the treatment of seizures. In people with epilepsy, Phenobarbital is used to prevent all types of seizures except absence seizur... read more

Phenytek (Phenytoin)

Overview
Phenytek is a prescription medication approved by the Food and Drug Administration (FDA) more than 50 years ago for the treatment of seizures. In people with epilepsy, Phenytek is most effective for p... read more

Qudexy XR (Topiramate)

Overview
Qudexy XR is a prescription drug approved by the Food and Drug Administration (FDA) to treat several types of seizures in people age 2 and older. Qudexy XR may be prescribed in cases of partial onset ... read more

Reedos (Lamotrigine)

Overview
Reedos is one brand name for Lamotrigine. According to the Australian Medicines Handbook (AMH), Lamotrigine is indicated for focal (partial) and generalised seizures.

Reedos is an antiepileptic, or... read more

Responsive neurostimulation (RNS)

Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). For people with frequent, disabling partial onset seizures imperfectly contro... read more

Right frontal lobectomy

Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their qual... read more

Rivotril (Clonazepam)

Overview
Rivotril is one brand name for Clonazepam. According to the Australian Medicines Handbook (AMH), Clonazepam is prescribed in conjunction with antiepileptic drugs (AEDs) if the AEDs alone are not adequ... read more

Sabril (Vigabatrin)

Overview
Sabril is approved by the Food and Drug Administration (FDA) to treat infantile spasms and, in combination with other medications, as treatment for refractory complex partial seizures in people 10 yea... read more

Tamate (Topiramate)

Overview
Tamate is one brand name for Topiramate. According to the Australian Medicines Handbook (AMH), Topiramate is indicated for focal (partial) seizures, generalised tonic-clonic seizures, and drop attack ... read more

Tegretol (Carbamazepine)

Overview
Tegretol is a prescription medication approved by the Food and Drug Administration (FDA) in 1968 for the treatment of seizures. In people with epilepsy, Tegretol is used to prevent most types of seizu... read more

Temporal lobe resection

Overview

Approximately 20 percent of people with epilepsy cannot adequately control their seizures with anti-epileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their q... read more

Temporal lobectomy

Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their quality of ... read more

Teril (Carbamazepine)

Overview
Teril is one brand name for Carbamazepine. According to the Australian Medicines Handbook (AMH), Carbamazepine is indicated for simple and complex focal (partial) seizures and generalised tonic-clonic... read more

Topamax (Topiramate)

Overview

Topamax is a prescription medication approved by the Food and Drug Administration (FDA) in 1997 for the treatment of complex and simple partial seizures, tonic-clonic seizures, and Lennox-Gastaut Sy... read more

Topiramate

Overview
According to the Australian Medicines Handbook (AMH), Topiramate is indicated for focal (partial) seizures, generalised tonic-clonic seizures, and drop attack seizures associated with Lennox-Gastaut s... read more

Tranxene (Clorazepate)

Tranxene is a prescription medication approved by the Food and Drug Administration (FDA) in 1972 to treat epilepsy. Tranxene is used in combination with other drugs to treat partial seizures that do not re... read more

Trileptal (Oxcarbazepine)

Overview
Trileptal is a prescription medication approved by the Food and Drug Administration (FDA) in 2000 for the treatment of partial seizures in people age two years and old. Trileptal may be prescribed as ... read more

Trokendi XR (Topiramate)

Overview
Trokendi XR is a prescription drug approved by the Food and Drug Administration (FDA) to treat several types of seizures in people age 6 and older. Trokendi XR may be prescribed as monotherapy (withou... read more

Vagus nerve stimulation (VNS)

Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their qual... read more

Valium (Diazepam)

Valium is a prescription medication approved by the Food and Drug Administration (FDA) in 1963. In cases of epilepsy, Valium is used in combination with other drugs to treat prolonged, repetitive, and clus... read more

Valprease (Valproate)

Overview
Valprease is one brand name for Valproate. According to the Australian Medicines Handbook (AMH), Valproate is indicated for primary generalised epilepsy and simple and complex focal (partial) seizures... read more

Valpro (Valproate)

Overview
Valpro is one brand name for Valproate. According to the Australian Medicines Handbook (AMH), Valproate is indicated for primary generalised epilepsy and simple and complex focal (partial) seizures.
... read more

Valproate

Overview
According to the Australian Medicines Handbook (AMH), Valproate is indicated for primary generalised epilepsy and simple and complex focal (partial) seizures.

Valproate is an antiepileptic, or drug... read more

Vimpat (Lacosamide)

Overview
Vimpat is a prescription medication approved by the Food and Drug Administration (FDA) in 2008 for the treatment of partial-onset seizures in people 17 and older. Doctors may also prescribe Vimpat for... read more

Zarontin (Ethosuximide)

Zarontin, also known by its drug name, Ethosuximide, is a prescription medication approved by the Food and Drug Administration (FDA) in 1960 for the treatment of absence seizures. Zarontin is frequently pr... read more

Zonegran (Zonisamide)

Overview

Zonegran is a prescription medication approved by the Food and Drug Administration (FDA) in 2000 for the treatment of many different types of seizures. Zonegran is usually prescribed as an adjunctiv... read more

Continue with Facebook
Sign up with your email
Already a Member? Log in